Source: International Congress 2019 – Evaluation of breathing in children when they are asleep, healthy or ill
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
M. Evangelisti (Rome, Italy), M. Barreto (Rome, Italy), M. Cecili (Rome, Italy), M. Villa (Rome, Italy). The use of systemic corticosteroids in children with obstructive sleep apnea syndrome. 911

Member's Comments

No comment yet.

Related content which might interest you: Compliance with CPAP/BiPAP treatment in obstructive sleep apnea syndrome patients Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010 Unrecognised systemic hypertension in patients with obstructive sleep apnoea Source: Eur Respir J 2006; 28: Suppl. 50, 643s Year: 2006 The influence of obesity in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 295s Year: 2002 Possibility of treating patients with obstructive sleep apnea syndrome and nocturnal asystoles using CPAP therapy Source: Annual Congress 2009 - Clinical aspects of sleep apnoea Year: 2009 Enuresis in obstructive sleep apnea syndrome patients Source: Annual Congress 2012 - Sleep apnoea: clinical topics Year: 2012 The symptom prevalence of obstructive sleep apnea syndrome in patients with asthma and COPD Source: Eur Respir J 2006; 28: Suppl. 50, 198s Year: 2006 Is obstructive sleep apnoea a comorbidity of COPD and is it involved in chronic systemic inflammatory syndrome? Source: Eur Respir J 2008; 31: 1381-1382 Year: 2008 The impact of obstructive sleep apnea syndrome on cardiovascular system in children Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain Year: 2011 Should patients with obstructive sleep apnea syndrome be screened for hypothyroidism? Source: Eur Respir J 2005; 26: Suppl. 49, 569s Year: 2005 The effect of concomitant COPD on obstructive sleep apnea syndrome severity and sleep structure Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity Year: 2011 Prevalence of metabolic syndrome in patients with hypertension and obstructive sleep apnea Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009 Acetazolamide improves central sleep apnea in patients with obstructive sleep apnea syndrome at altitude Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea Year: 2009 Airway inflammation in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 274s Year: 2002 Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010 Prevalence of very severe obstructive sleep apnea syndrome from symptomatic patients. Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea Year: 2019 PAI-uPA system in patients with obstructive sleep apnea syndrome (OSAS) in CPAP treatment Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing Year: 2012 Vasoconstriction during the night in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 419s Year: 2006 Comorbidities of obstructive sleep apnoea syndrome Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities Year: 2011 Predictors of long-term PAP-adherence in obstructive sleep apnea syndrome Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 Prevalence of metabolic syndrome from patient with obstructive sleep apnea and hypertension Source: International Congress 2019 – Current perspectives in sleep-disordered breathing Year: 2019